Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$191.17 - $325.63 $557,834 - $950,188
-2,918 Reduced 59.16%
2,014 $655,000
Q4 2023

Feb 05, 2024

SELL
$160.99 - $215.69 $490,536 - $657,207
-3,047 Reduced 38.19%
4,932 $939,000
Q3 2023

Nov 13, 2023

SELL
$194.33 - $283.97 $2.47 Million - $3.61 Million
-12,697 Reduced 61.41%
7,979 $1.59 Million
Q2 2023

Aug 10, 2023

BUY
$223.05 - $302.68 $1.47 Million - $1.99 Million
6,584 Added 46.72%
20,676 $5.9 Million
Q1 2023

May 09, 2023

SELL
$175.41 - $217.92 $5.13 Million - $6.37 Million
-29,234 Reduced 67.47%
14,092 $3.06 Million
Q4 2022

Feb 08, 2023

SELL
$204.38 - $296.82 $2.08 Million - $3.02 Million
-10,164 Reduced 19.0%
43,326 $8.91 Million
Q3 2022

Nov 04, 2022

BUY
$195.21 - $310.53 $1.92 Million - $3.05 Million
9,821 Added 22.49%
53,490 $14.9 Million
Q2 2022

Jul 29, 2022

BUY
$115.91 - $214.48 $345,875 - $640,008
2,984 Added 7.33%
43,669 $8.35 Million
Q1 2022

May 05, 2022

SELL
$127.96 - $207.36 $1.41 Million - $2.28 Million
-10,987 Reduced 21.26%
40,685 $8.42 Million
Q4 2021

Jan 21, 2022

BUY
$165.13 - $241.83 $721,948 - $1.06 Million
4,372 Added 9.24%
51,672 $9.21 Million
Q3 2021

Nov 08, 2021

BUY
$163.99 - $235.57 $4.11 Million - $5.9 Million
25,063 Added 112.71%
47,300 $9.73 Million
Q2 2021

Aug 04, 2021

BUY
$131.45 - $201.49 $2.69 Million - $4.12 Million
20,430 Added 1130.6%
22,237 $4.22 Million
Q1 2021

May 10, 2021

SELL
$92.73 - $142.05 $203,356 - $311,515
-2,193 Reduced 54.83%
1,807 $235,000
Q4 2020

Feb 08, 2021

BUY
$67.44 - $103.72 $96,439 - $148,319
1,430 Added 55.64%
4,000 $414,000
Q2 2020

Aug 05, 2020

BUY
$27.25 - $47.53 $70,032 - $122,152
2,570 New
2,570 $121,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.